Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs directed at growing the horizons of cytokine-based immunotherapy, specifically for cancers where remedy options remain limited. Make use of the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Check out https://financefeeds.com/liquid-mercury-and-dvin-labs-partner-to-launch-investment-grade-wine-trading-platform/